These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28684173)

  • 1. Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.
    Chiesa PA; Cavedo E; Lista S; Thompson PM; Hampel H;
    Trends Neurosci; 2017 Aug; 40(8):469-480. PubMed ID: 28684173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease.
    Demirtaş M; Falcon C; Tucholka A; Gispert JD; Molinuevo JL; Deco G
    Neuroimage Clin; 2017; 16():343-354. PubMed ID: 28861336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.
    Hao X; Yao X; Yan J; Risacher SL; Saykin AJ; Zhang D; Shen L;
    Neuroinformatics; 2016 Oct; 14(4):439-52. PubMed ID: 27277494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease.
    Forouzannezhad P; Abbaspour A; Fang C; Cabrerizo M; Loewenstein D; Duara R; Adjouadi M
    J Neurosci Methods; 2019 Apr; 317():121-140. PubMed ID: 30593787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle.
    Chételat G
    J Alzheimers Dis; 2018; 64(s1):S199-S211. PubMed ID: 29504542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise and persistent feature to study brain resting-state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative.
    Kuang L; Han X; Chen K; Caselli RJ; Reiman EM; Wang Y;
    Hum Brain Mapp; 2019 Mar; 40(4):1062-1081. PubMed ID: 30569583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered static and dynamic functional network connectivity in Alzheimer's disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalities.
    Fu Z; Caprihan A; Chen J; Du Y; Adair JC; Sui J; Rosenberg GA; Calhoun VD
    Hum Brain Mapp; 2019 Aug; 40(11):3203-3221. PubMed ID: 30950567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's disease.
    Chong JSX; Liu S; Loke YM; Hilal S; Ikram MK; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Brain; 2017 Nov; 140(11):3012-3022. PubMed ID: 29053778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity factor contributes to altered brain functional networks in individuals at risk for Alzheimer's disease: Neuroimaging-genetic evidence.
    Bai F; Shi Y; Yuan Y; Xie C; Zhang Z
    Brain Behav Immun; 2016 Aug; 56():84-95. PubMed ID: 26899953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.
    Habib M; Mak E; Gabel S; Su L; Williams G; Waldman A; Wells K; Ritchie K; Ritchie C; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():88-104. PubMed ID: 28342882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy.
    Pievani M; Filippini N; van den Heuvel MP; Cappa SF; Frisoni GB
    Nat Rev Neurol; 2014 Nov; 10(11):620-33. PubMed ID: 25287597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents.
    Axelrud LK; Sato JR; Santoro ML; Talarico F; Pine DS; Rohde LA; Zugman A; Junior EA; Bressan RA; Grassi-Oliveira R; Pan PM; Hoffmann MS; Simioni AR; Guinjoan SM; Hakonarson H; Brietzke E; Gadelha A; Pellegrino da Silva R; Hoexter MQ; Miguel EC; Belangero SI; Salum GA
    Neurobiol Aging; 2019 Oct; 82():10-17. PubMed ID: 31376729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease.
    Wisch JK; Roe CM; Babulal GM; Schindler SE; Fagan AM; Benzinger TL; Morris JC; Ances BM
    J Alzheimers Dis; 2020; 74(4):1085-1095. PubMed ID: 32144983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel SJ; Metzger CD; Brosseron F; Buerger K; Brueggen K; Catak C; Diesing D; Dobisch L; Fliebach K; Franke C; Heneka MT; Kilimann I; Kofler B; Menne F; Peters O; Polcher A; Priller J; Schneider A; Spottke A; Spruth EJ; Thelen M; Thyrian RJ; Wagner M; Düzel E; Jessen F; Dyrba M;
    J Alzheimers Dis; 2018; 64(3):801-813. PubMed ID: 29914027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.
    Roussotte FF; Daianu M; Jahanshad N; Leonardo CD; Thompson PM
    Brain Imaging Behav; 2014 Jun; 8(2):217-233. PubMed ID: 24142306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Cavedo E; Chiesa PA; Houot M; Ferretti MT; Grothe MJ; Teipel SJ; Lista S; Habert MO; Potier MC; Dubois B; Hampel H; ;
    Alzheimers Dement; 2018 Sep; 14(9):1204-1215. PubMed ID: 30201102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    Hafkemeijer A; Möller C; Dopper EG; Jiskoot LC; van den Berg-Huysmans AA; van Swieten JC; van der Flier WM; Vrenken H; Pijnenburg YA; Barkhof F; Scheltens P; van der Grond J; Rombouts SA
    J Alzheimers Dis; 2017; 55(2):521-537. PubMed ID: 27662284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.